HTG Molecular Diagnostics, Inc.

Industry

  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Laboratory Testing Services
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
    • Chemistry, Immunoassay
  • Pharmaceuticals
See more in Biomedtracker

Latest on HTG Molecular Diagnostics, Inc.

Scrip

Stock Watch: Reading The Tea Leaves For Pharma Q1 Earnings

 
• By Andy Smith

About two weeks before the onset of the first-quarter 2021 earnings season for life science companies, there were two preannouncements in 24 hours. While neither company was a therapeutic drug company

In Vivo

Immuno-Oncology Is Making Pharma Step Up Its Diagnostics Game

 
• By Alex Vadas

Immuno-oncology represents a paradigm shift in cancer treatment, with the first wave of PD-1/PD-L1 checkpoint inhibitors such as Opdivo (nivolumab, from Bristol-Myers Squibb Co. ) and Keytruda (

In Vivo

Deals Shaping The Medical Industry, February 2018

 
• By Beth Allan, Deanna Kamienski, and Maureen Riordan

IN VITRO DIAGNOSTICS Financings HTG Molecular Diagnostics Inc. HTG Molecular Diagnostics Inc. netted $37.9mm through a public offering of 13.9mm common shares (including the overallotment) at $2.9

In Vivo

Execs On The Move, April 2017

 
• By Regina Paleski

Company Changes ADAMS , Derek, PhD To: bluebird bio Inc. , Chief Technology & Mfg. Officer (March) From: Evelo Biosciences, SVP, CMC Phone: 339-499-9300 ARBET-ENGELS , Christophe, MD, PhD To: